(Q94469287)
Statements
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza (English)
Timothy R Abbott
Girija Dhamdhere
Yanxia Liu
Xueqiu Lin
Laine Goudy
Leiping Zeng
Augustine Chemparathy
Stephen Chmura
Nicholas S Heaton
Robert Debs
Tara Pande
Drew Endy
Marie F La Russa
David B Lewis